Camptothecin liposomal (Aphios)

喜树碱脂质体 (Aphios)

Report date: 2025/06/24 16:52:56

Base Information

Drug NameCamptothecin liposomal (Aphios)
Drug Alias NameLiposome encapsulated camptothecinCamposomes
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAphios Corporation
China Registration ClassN/A

Develop Information

Active CompaniesAphios Corporation
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A